Table 4.
Comparison of the Distribution of Residual Patellar Thickness
Thickness (mm)a) | Group Ab) | Group Bc) | ||
---|---|---|---|---|
| ||||
No. of subjects | Cumulative (%)d) | No. of subjects | Cumulative (%)d) | |
<12d) | 23 | 7.5 | 6 | 2.1 |
12–14 | 88 | 36.9 | 66 | 23.9 |
14–16 | 115 | 75.3 | 122 | 64.8 |
16–18 | 52 | 92.5 | 57 | 83.8 |
18–20 | 16 | 97.9 | 36 | 95.8 |
20–22 | 6 | 100 | 9 | 98.6 |
24–26 | 0 | 100 | 2 | 99.3 |
26–28 | 0 | 100 | 0 | 99.3 |
28–30 | 0 | 100 | 2 | 100 |
Thickness of the residual patella.
Group A patients who received the Attune prosthesis.
Group B patients who received the PFC Sigma prosthesis.
The proportion of high-risk cases with a residual patellar thickness of less than 12 mm was significantly different between the groups (p=0.003).